HCA Healthcare, Inc. $HCA Shares Acquired by Mirabella Financial Services LLP

Mirabella Financial Services LLP lifted its position in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 112.2% in the third quarter, Holdings Channel reports. The firm owned 12,715 shares of the company’s stock after acquiring an additional 6,724 shares during the period. Mirabella Financial Services LLP’s holdings in HCA Healthcare were worth $5,408,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of the business. Capital World Investors raised its position in HCA Healthcare by 3.8% in the 3rd quarter. Capital World Investors now owns 4,959,336 shares of the company’s stock valued at $2,113,662,000 after purchasing an additional 179,443 shares during the last quarter. Norges Bank acquired a new stake in shares of HCA Healthcare in the 2nd quarter valued at approximately $1,152,408,000. Arrowstreet Capital Limited Partnership raised its position in HCA Healthcare by 1.8% in the third quarter. Arrowstreet Capital Limited Partnership now owns 2,065,225 shares of the company’s stock worth $880,199,000 after acquiring an additional 36,414 shares in the last quarter. Viking Global Investors LP grew its stake in shares of HCA Healthcare by 58.5% during the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares during the period. Finally, Legal & General Group Plc lifted its stake in shares of HCA Healthcare by 0.8% in the third quarter. Legal & General Group Plc now owns 1,124,511 shares of the company’s stock valued at $479,267,000 after purchasing an additional 8,478 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on HCA shares. UBS Group upped their price target on HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a report on Monday, February 23rd. KeyCorp set a $503.00 price target on HCA Healthcare in a research report on Wednesday, January 28th. Jefferies Financial Group boosted their price objective on shares of HCA Healthcare from $535.00 to $590.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Truist Financial lifted their target price on shares of HCA Healthcare from $520.00 to $546.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research note on Wednesday, March 4th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $537.73.

View Our Latest Stock Analysis on HCA

Insider Activity

In related news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total value of $2,020,000.00. Following the transaction, the senior vice president owned 44,379 shares in the company, valued at approximately $22,411,395. The trade was a 8.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Michael R. Mcalevey sold 1,694 shares of the company’s stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the completion of the transaction, the executive vice president directly owned 8,853 shares in the company, valued at approximately $4,721,924.61. The trade was a 16.06% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 15,214 shares of company stock valued at $7,797,595 over the last ninety days. 1.30% of the stock is owned by company insiders.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $525.12 on Tuesday. The firm’s 50-day moving average is $508.00 and its two-hundred day moving average is $471.31. The stock has a market capitalization of $117.43 billion, a P/E ratio of 18.50, a P/E/G ratio of 1.64 and a beta of 1.34. HCA Healthcare, Inc. has a 12-month low of $314.43 and a 12-month high of $556.52.

HCA Healthcare (NYSE:HCAGet Free Report) last released its earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping the consensus estimate of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The firm had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same period in the previous year, the company earned $6.22 EPS. HCA Healthcare’s revenue for the quarter was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be paid a dividend of $0.78 per share. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Tuesday, March 17th. HCA Healthcare’s payout ratio is 10.99%.

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Read More

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.